FOLFOXIRI With or Without Panitumumab in Metastatic Colorectal Cancer (VOLFI)

NCT01328171 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

93

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Colorectal Cancer

Interventions

DRUG: FOLFOXIRI + Panitumumab
DRUG: FOLFOXIRI

Sponsor

AIO-Studien-gGmbH

Collaborators

[object Object]
[object Object]